About Dxcover
Dxcover is a company based in Glasgow (United Kingdom) founded in 2016 by Matthew J Baker and Mark Hegarty.. Dxcover has raised $15.45 million across 4 funding rounds from investors including Mercia, University of Strathclyde and Macmillan Cancer Support. The company has 16 employees as of January 31, 2021. Dxcover offers products and services including PANAROMIC™ Platform and DROP DRY DETECT™. Dxcover operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Glasgow, United Kingdom
- Employees 16 as on 31 Jan, 2021
- Founders Matthew J Baker, Mark Hegarty
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Dxcover Limited
- Date of Incorporation 16 May, 2016
- Jurisdiction GLASGOW, SCOTLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.45 M (USD)
in 4 rounds
-
Latest Funding Round
$6.2 M (USD), Series A
Feb 03, 2025
-
Investors
Mercia
& 10 more
-
Employee Count
16
as on Jan 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dxcover
Dxcover offers a comprehensive portfolio of products and services, including PANAROMIC™ Platform and DROP DRY DETECT™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables early detection of multiple cancers using AI and spectroscopy.
Facilitates liquid biopsy for cancer diagnosis through spectral analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of Dxcover
Dxcover has successfully raised a total of $15.45M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.2 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $6.2M
-
First Round
First Round
(21 Dec 2022)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series A - Dxcover | Valuation | Eos Advisory | |
| Jun, 2023 | Amount | Grant - Dxcover | Valuation |
investors |
|
| Feb, 2023 | Amount | Series A - Dxcover | Valuation | Norcliffe Capital , SIS Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Dxcover
Dxcover has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Mercia, University of Strathclyde and Macmillan Cancer Support. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in science and technology is managed by Eos.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on social impact companies
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Dxcover
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Dxcover
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dxcover Comparisons
Competitors of Dxcover
Dxcover operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Dxcover
Frequently Asked Questions about Dxcover
When was Dxcover founded?
Dxcover was founded in 2016 and raised its 1st funding round 6 years after it was founded.
Where is Dxcover located?
Dxcover is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Who is the current CEO of Dxcover?
Mark Hegarty is the current CEO of Dxcover. They have also founded this company.
Is Dxcover a funded company?
Dxcover is a funded company, having raised a total of $15.45M across 4 funding rounds to date. The company's 1st funding round was a Series A of $9.25M, raised on Dec 21, 2022.
How many employees does Dxcover have?
As of Jan 31, 2021, the latest employee count at Dxcover is 16.
What does Dxcover do?
Dxcover was founded in 2016 in Glasgow, United Kingdom, within the health technology sector. An AI-powered platform is utilized by the company, integrating novel hardware with algorithms to analyze blood samples. Early detection of brain tumors and other common cancers is facilitated through this device. Operations focus on diagnostic tools for oncology, serving medical applications in the UK and beyond.
Who are the top competitors of Dxcover?
Dxcover's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
What products or services does Dxcover offer?
Dxcover offers PANAROMIC™ Platform and DROP DRY DETECT™.
Who are Dxcover's investors?
Dxcover has 11 investors. Key investors include Mercia, University of Strathclyde, Macmillan Cancer Support, Scottish Enterprise, and European Union.